**Question:** Choose the drug whose single oral dose affords clinical cure of uncomplicated malaria caused by chloroquine sensitive/resistant P. falciparum as well as P. vivax:

A. Artemisinin
B. Atovaquone-proguanil
C. Mefloquine
D. Quinine

**Correct Answer:** D. Quinine

**Core Concept:** Malaria is a life-threatening parasitic infection caused by Plasmodium species, particularly P. falciparum and P. vivax. Antimalarial drugs play a critical role in its treatment. Antimalarial drugs can be broadly categorized into two types: rapid-acting drugs and slow-acting drugs.

**Why the Correct Answer is Right:** Quinine is a slow-acting antimalarial drug that has been used for decades to treat uncomplicated malaria caused by P. falciparum and P. vivax. Its mechanism of action involves inhibition of the parasite's ability to synthesize nucleic acids, leading to parasite death. Quinine is effective against chloroquine-resistant strains of P. falciparum and P. vivax.

**Why Each Wrong Option is Incorrect:**

A. Artemisinin (Artemether): Artemisinin is a rapid-acting drug, which is combined with other drugs such as dihydroartemisinin, lumefantrine, or mefloquine to form Artemisinin Combination Therapies (ACTs). ACTs are fast acting and effective against a wide range of Plasmodium species. However, quinine is not an ACT and is slower acting than ACTs.

B. Atovaquone-proguanil (Malarone): Atovaquone-proguanil is an ACT used to treat uncomplicated malaria, but it is not as effective against chloroquine-resistant strains of P. falciparum and P. vivax as quinine.

C. Mefloquine: Mefloquine is a slow-acting antimalarial drug, and while it is effective against chloroquine-resistant strains of P. falciparum and P. vivax, it is not as effective as quinine.

D. Quinine: As explained above, quinine is a slow-acting drug, but it is effective against chloroquine-resistant strains of P. falciparum and P. vivax.

**Clinical Pearl:** Quinine is prescribed for severe malaria cases, particularly in pregnant women and children due to its lower toxicity profile compared to other antimalarial drugs. It is commonly used in combination with other drugs, such as clindamycin or doxycycline, for the treatment of uncomplicated malaria.